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Abstract
Background: Diabetes has negative, and exercise training positive, effects on the skeletal muscle
vasculature, but the mechanisms are not yet fully understood. In the present experiment the effects
of running exercise on the mRNA expression of pro- and antiangiogenic factors were studied in
healthy and diabetic skeletal muscle. The responses in capillaries and muscle fibers, collected from
the muscle with laser capture microdissection, were also studied separately.
Methods: Healthy and streptozotocin-induced diabetic mice were divided into sedentary and
exercise groups. Exercise was a single bout of 1 h running on a treadmill. Gastrocnemius muscles
were harvested 3 h and 6 h post exercise, and angiogenesis-related gene expressions were analyzed
with real-time PCR. In addition to muscle homogenates, capillaries and muscle fibers were
collected from the muscle with laser capture microdissection method and analyzed for vascular
endothelial growth factor-A (VEGF-A) and thrombospondin-1 (TSP-1) mRNA expression.
Results: Of the proangiogenic factors, VEGF-A and VEGF receptor-2 (VEGFR-2) mRNA
expression increased significantly (P < 0.05) in healthy skeletal muscle 6 h post exercise. VEGF-B
also showed a similar trend (P = 0.08). No significant change was observed post exercise in diabetic
muscles in the expression of VEGF-A, VEGFR-2 or VEGF-B. The expression of angiogenesis
inhibitor TSP-1 and angiogenic extracellular matrix protein Cyr61 were significantly increased in
diabetic muscles (P < 0.05–0.01). Capillary mRNA expression resembled that in the muscle
homogenates, however, the responses were greater in capillaries compared to muscle
homogenates and pure muscle fibers.
Conclusion: The present study is the first to report the effects of a single bout of exercise on the
expression of pro- and antiangiogenic factors in diabetic skeletal muscle, and it provides novel data
about the separate responses in capillaries and muscle fibers to exercise and diabetes. Diabetic
mice seem to have lower angiogenic responses to exercise compared to healthy mice, and they
show markedly increased expression of angiogenesis inhibitor TSP-1. Furthermore, exercise-
induced VEGF-A expression was shown to be greater in capillaries than in muscle fibers.
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Diabetes is a risk factor for peripheral vascular diseases,
and it is associated with impaired collateral vessel growth
in skeletal muscle [1,2]. Angiogenesis, the growth of new
blood vessels from pre-existing ones, is controlled by
complex pathways with both pro- and antiangiogenic fac-
tors [3]. Recently, both type 1 and type 2 diabetes have
been shown to affect angiogenic growth factors and inhib-
itors in skeletal muscle [4,5]. In our previous study strep-
tozotocin-induced diabetes decreased the mRNA levels of
several proangiogenic proteins and increased those of
antiangiogenic ones in mouse skeletal muscle [4]. This
change in the balance between stimulators and inhibitors
may be one of the reasons for the markedly increased risk
for peripheral cardiovascular complications in diabetes.
The effects of exercise on angiogenesis in skeletal muscle
are known to be opposite to those of diabetes. Exercise-
induced increase in skeletal muscle capillarization is a
well-known phenomenon in healthy humans and in ani-
mals [6], and it has been linked to the increased expres-
sion of angiogenic growth factors after exercise. Diabetes,
in turn, has been demonstrated to impair skeletal muscle
and cardiac angiogenesis, and the mechanisms underlying
this have generated much interest recently [2,7-12]. Stud-
ies on capillary density and changes in capillarization
after endurance exercise training in diabetic animals and
patients have produced conflicting results [13-15]. Our
earlier results showed exercise training to have some pos-
itive effects on the basal levels of angiogenic growth fac-
tors in diabetic skeletal muscle [4], and this is to our
knowledge the only study to present exercise training-
induced changes in the angiogenic factors in diabetic skel-
etal muscle. The acute effects in diabetic muscle have not
been reported. In healthy skeletal muscle several animal
and human studies have shown increased VEGF-A expres-
sion after acute exercise [16-18] or electrical stimulation
[19,20].
In addition to muscle fibers, several other cell types are
present in the extracellular matrix, such as endothelial
cells, pericytes, and fibroblasts. Skeletal muscle angiogen-
esis has previously been studied using muscle homoge-
nates, which contain all the cell types present in the
muscle tissue. However, in the case of angiogenesis it is of
interest to study responses in capillary endothelial cells
and in muscle fibers separately. Both these cell types are
known to produce vascular endothelial growth factor -A
(VEGF-A), which is considered the main angiogenic
growth factor. Another approach has been to study
endothelial cells and myocytes in the cell culture, but this
does not represent the in vivo environment in the muscle.
Recently, Milkiewicz and Haas demonstrated the feasibil-
ity of the laser capture microdissection (LCM) method in
the study of capillary-specific gene expression from heter-
ogeneous tissue such as skeletal muscle [21]. They showed
that in capillaries, which were isolated from overloaded
skeletal muscles, mechanical stretch increased the expres-
sion of HIF-1α and MMP-2. This method provides a tool
to study responses separately in different cell types from
heterogeneous tissues.
Our exercise training study suggested that regular training
could increase the basal mRNA levels of angiogenic
growth factors in diabetic muscle. In the present study the
aim was to compare the responses of pro- and antiang-
iogenic factors to a single bout of running exercise in
healthy and diabetic muscle to exercise. In healthy skeletal
muscle the acute proangiogenic responses have been stud-
ied, but the responses in diabetic muscles have not been
presented. In addition to skeletal muscle homogenates we
studied the expression levels separately in capillaries
within the muscle and in pure muscle fibers using the
LCM method. We focused on the recovery period 3 h and
6 h post exercise, when angiogenesis processes in capillar-
ies are likely to occur.
Methods
Experimental set-up
All experimental procedures were approved by the Animal
Care and Use Committee of the University of Jyväskylä,
Finland. Animals were housed in standard conditions
(temperature 22°C, humidity 60 ± 10%, light from 8.00
am to 8.00 pm), and they had free access to tap water and
food pellets (R36, Labfor, Stockholm, Sweden).
Adult male NMRI mice (n = 48, Harlan, the Netherlands)
aged 10–15 weeks were randomly assigned into healthy
and diabetic groups. The diabetic group received a single
peritoneal injection of streptozotocin (STZ, Sigma-
Aldrich, France, 180 mg/kg) dissolved in sodium citrate
buffer solution (0.1 mol/l, pH 4.5) to induce experimen-
tal type 1 diabetes. The other group received a sham injec-
tion of an equal volume of the buffer. Diabetes was
confirmed three days after the injection by a blood glu-
cose test (HemoCue B-Glucose analyzer, Ängleholm, Swe-
den). Mice were characterized as diabetic when their
blood glucose values were greater than 15 mmol/L, and
they were not treated with insulin during the experiment.
Ten days after injections the mice were divided into three
healthy and three diabetic groups (n = 8). One healthy
and one diabetic group served as sedentary controls with-
out exercise (H and D), and the four other groups per-
formed 1 h running exercise on a treadmill (speed 21 m/
min with an incline of 2.5°). One healthy and one dia-
betic exercise group were sacrificed 3 h after the end of the
exercise (HE3 and DE3), and the other two groups 6 h
after (HE6 and DE6). Before the actual experiment all
mice were familiarized with treadmill running. Only
those mice, which were able to run on a treadmill werePage 2 of 10
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About 10% of the mice were excluded from the experi-
ment, because of their inability to run on a treadmill.
Tissue preparation
Mice were killed by cervical dislocation and gastrocne-
mius muscles were immediately removed. The proximal
part of the right gastrocnemius muscle was mounted in an
O.C.T. embedding medium (Miles, Elkhart, USA) under a
microscope to orientate muscle fibers vertically and snap
frozen in liquid nitrogen-cooled isopentane. The distal
part of the muscle was snap frozen in liquid nitrogen and
stored at -80°C for further analysis. The heterogeneity of
the muscle was taken into account by taking whole cross-
sections for RNA extraction from the same part of the
muscle.
RNA extraction
Total RNA was isolated from the gastrocnemius muscle
with Trizol Reagent (Invitrogen, Carlsbad, USA) accord-
ing to the manufacturer's protocol. The concentration and
purity of RNA was determined spectrophotometrically at
the wavelengths 260 and 280 nm. Integrity was checked
with agarose gel electrophoresis. RNA was reverse-tran-
scribed to cDNA with a High Capacity cDNA Archive Kit
(Applied Biosystems, Foster City, USA).
Laser capture microdissection (LCM)
LCM was used to collect capillaries and pure muscle fibers
from the gastrocnemius muscle. Three mice from groups
C, D, HE6 and DE6, comprising a total of 24 LCM samples
(capillaries and muscle fibers from each animal), were
analyzed for the GAPDH-normalized expression of VEGF-
A and TSP-1 in capillaries and muscle fibers. The proce-
dures used to collect capillaries and muscle fibers from
skeletal muscle were adopted from Milkiewicz & Haas
(2005) [21]. Cryosections (8 μm) were cut on uncoated
glass slides, immediately fixed with cold acetone and
stored at -80°C. Samples were further processed within
two days. All equipment was treated with a RNase Away-
solution (QBiogene, Morgan Irvine, CA) to prevent RNA
degradation. Immediately after taking the samples out of
the freezer, capillaries were stained with Isolectin GS-IB4
from Griffonia simplicifolia Alexa Fluor 488 conjugate
(Molecular Probes), which was diluted in sterile PBS with
SUPERaseIn RNAase inhibitor (Ambion, Austin, USA).
After a brief wash the samples were properly dehydrated
and debris was removed with PrepStrip (Arcturus Engi-
neering, Molecular Devices Corporation, Sunnyvale,
USA). Laser capture microdissection for capillaries and
pure muscle was performed with a Veritas microdissection
system (Arcturus Engineering). From each sample 750–
1000 capillaries and 1100–2300 similar laser pulses from
the muscle fibers were randomly collected with CapSure
LCM caps (Arcturus Engineering) from all parts of the
muscle, including both the deep oxidative and the super-
ficial glycolytic portions. Capillaries were distinguished
by size (<10 μm) from larger blood vessels. RNA was
extracted with a PicoPure RNA isolation kit (Arcturus
Engineering) according to the protocol. RNA was tran-
scribed to cDNA with a Sensiscript reverse transcription
kit (Qiagen) at 42°C for 2 h, using both random and oligo
(dT) primers (Ambion).
Real-time quantitative PCR
The ABI Prism Sequence Detection System 7300 (Applied
Biosystems) was used to perform TaqMan probe-based
real-time PCR reactions. TaqMan primer and probe sets
for VEGF-A (Mm00437304_m1), VEGF-B
(Mm00442102_m1), VEGFR-1 (Mm00438980_m1),
VEGFR-2 (Mm00440099_m1), TSP-1
(Mm00449022_m1) and Cyr61 (Mm00487498_m1)
were designed and synthesized by Applied Biosystems.
Primer pairs were designed so that they overlapped an
exon-exon boundary to avoid interference from possible
genomic DNA contamination. As an endogenous control
to correct for potential variation in RNA loading, GAPDH
(Mm99999915_g1) was used as a housekeeping gene.
GAPDH was chosen among the commonly used house-
keeping genes based on the microarray results from our
previous study with similar experimental diabetes and
exercise protocol [4], and a study by Yechoor et al. [22]
with similar streptozotocin-induced diabetes and skeletal
muscle samples. Furthermore, it is considered the most
stable internal control in endurance exercise studies
[23,24]. The stability of the GAPDH expression was also
examined between the experimental groups in relation to
the amount of total RNA. ANOVA P-value was 0.988 and
the mean values and SD were very similar in all groups,
indicating that GAPDH was not affected by diabetes or
exercise in our samples. Target genes in the muscle
homogenates were quantified according to the corre-
sponding gene-specific standard curve. The expression of
VEGF-A and TSP-1 was analyzed in the LCM samples. The
comparative CT method was utilized for the LCM samples
as outlined in the Applied Biosystems User Bulletin 2
(Applied Biosystems). The amplification efficiencies of
the target genes and GAPDH were checked to be equal
over a range of serial dilutions. All samples were analyzed
in triplicate.
Statistical analysis
Statistical analyses were carried out using SPSS for Win-
dows statistical software release 13.0 (SPSS, Chigago, IL,
USA). Data were analyzed for normality and the non-par-
ametric Kruskall-Wallis test with Mann-Whitney U tests
were used to analyze differences between groups. Pearson
correlation was used to detect similar expression patterns
between the studied genes and glucose concentrations.
The significance level was set at P < 0.05. Changes in thePage 3 of 10
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fold-change from healthy control, which was set to 1.
Results
Blood glucose and body weight
Whole blood glucose was significantly higher in the dia-
betic than healthy mice (35.6 ± 6.7 (mean ± SD) vs. 8.1 ±
1.1 mmol/L, P < 0.001) on the day of the experiment. The
diabetic and healthy mice did not differ in body weight at
the beginning of the experiment (36.8 ± 2.3 vs. 36.9 ± 3.2
g), but after ten days of diabetes, the diabetic mice had sig-
nificantly reduced body weight compared to the healthy
mice (33.1 ± 4.1 vs. 37.9 ± 3.3 g, P < 0.001).
Messenger RNA in skeletal muscle homogenates
VEGF-A and VEGFR-2 mRNA expression increased signif-
icantly (P < 0.05) in the healthy mice 6 h post exercise
(Fig. 1). VEGF-B also showed similar trend at 6 h post
exercise, but the increase was not statistically significant (P
= 0.08). No significant change was observed in the dia-
betic mice in the expression of VEGF-A, VEGFR-2 or
VEGF-B post exercise. VEGFR-1 expression was not
affected by exercise in either healthy or diabetic mice.
The expression of TSP-1 was increased in exercised dia-
betic groups DE3 and DE6 compared to the healthy con-
trol group and the respective healthy exercised groups (P
< 0.01) (Fig. 1). The diabetic sedentary mice (D) also had
higher expression compared to the healthy control group,
but this was not statistically significant due to the large
variation. Diabetes also increased the expression of Cyr61
(Fig. 1). Cyr61 expression was higher in all the diabetic
groups compared to the healthy control group and the
respective exercise groups (P < 0.05–0.01).
VEGF-A expression levels correlated positively with the
expression of VEGF-B (P < 0.001), VEGFR-1 (P < 0.01)
and VEGFR-2 (P < 0.001) (Fig. 2). VEGF-B also correlated
positively with both VEGFR-1 and -2 (P < 0.01-0.001).
High glucose levels were associated with increased expres-
sion levels of TSP-1 and Cyr61 (P < 0.001) and decreased
expression levels of VEGF-B (P < 0.05). TSP-1 and Cyr61
expression also correlated strongly (P < 0.001) with each
other. The variation in the expression of Cyr61 and TSP-1
was markedly greater in the diabetic than in the healthy
mice, as can be seen in figures 2g and 2h.
Messenger RNA in capillaries and muscle fibers
In the capillaries collected from the gastrocnemius muscle
VEGF-A expression increased significantly in HE6 com-
pared to C (Fig. 3a). VEGF-A expression in DE6 did not
differ significantly from D, although it was slightly higher
in DE6. Capillary expression of TSP-1 decreased in HE6
and increased in D and DE6 compared to healthy controls
(Fig. 3b).
In the pure skeletal muscle fibers obtained with LCM,
VEGF-A tended to increase in the exercised groups com-
pared to sedentary groups, but these were not statistically
significant (Fig. 3C). TSP-1 expression was higher in DE6
than D (P < 0.05), and it was also more than 4-fold higher
in DE6 compared to the healthy groups, but this was not
statistically significant (Fig. 3D).
Discussion
In the present study we report the effects of a single bout
of exercise on the expression of pro- and antiangiogenic
factors in diabetic skeletal muscle. The results also provide
novel data about exercise- and diabetes-induced changes
in the expression of VEGF-A and TSP-1 separately in cap-
illaries and muscle fibers. Our results showed that in the
healthy mice the mRNA expression of VEGF-A and its
receptor VEGFR-2 were increased, by 25% and 29%
respectively, 6 h post exercise in the skeletal muscle
homogenates. VEGF-B expression also showed a similar
trend (15%, P = 0.08). Increases in VEGF-A and VEGFR-2
have been demonstrated earlier in healthy muscles e.g.
[16,25-27]. The present results suggest that the expression
of VEGF-B may also be affected by exercise; however the
increase was not statistically significant. VEGF-B belongs
to the same protein family as VEGF-A, and it plays a role
in the vascularization of adult and embryonic tissues, par-
ticularly in metabolically highly active tissues such as
heart and skeletal muscle [28]. However, it has not been
studied to the same extent as VEGF-A and its exact role
remains yet to be determined. In diabetic mice there was
also a trend for increased expression of VEGF-A (17%)
and VEGFR-2 (20%) 6 h post exercise, but these changes
were not statistically significant. This suggests that ang-
iogenic responses to a single bout of exercise in skeletal
muscle are reduced in diabetic compared to healthy mice.
The expression of angiogenic growth factors in diabetic
muscles may, nevertheless, be upregulated by exercise to
some extent. This is supported by the results obtained
from our previous exercise training study, where basal
mRNA expression of VEGF-A and VEGF-B were increased
in trained compared to sedentary diabetic mice [4]. In that
study, sedentary diabetic mice exhibited decreased basal
expression of VEGF-A and VEGF-B compared to the
healthy mice. In the present experiment, there was no dif-
ference in the basal expression after 10 days of diabetes,
which can be considered as acute diabetes. Contradictory
findings exist in the literature about the effects of diabetes
or hyperglycemia on the expression of VEGF-A. Several
studies have shown decreased expression of VEGF-A in
diabetic skeletal muscle or myocardium [9,29-31]. Some
studies have reported no change in the expression of
VEGF-A due to hyperglycemia [8,32], while others have
shown increased expression compared to healthy muscle
or myocardium [10,33]. This demonstrates the complex-
ity of the regulation of angiogenic signaling, and how itPage 4 of 10
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Effects of 1 h running exercise on skeletal muscle mRNA expression of VEGF-A, VEGF-B, VEGFR-1, VEGFR-2, TSP-1 and Cyr61 in healthy (black bars) and diab ic (white bars) miceFigure 1
Effects of 1 h running exercise on skeletal muscle mRNA expression of VEGF-A, VEGF-B, VEGFR-1, VEGFR-2, TSP-1 and 
Cyr61 in healthy (black bars) and diabetic (white bars) mice. The results are expressed as a fold-change (mean ± SE) from the 
healthy control group, which is set to 1. * P < 0.05 vs. healthy control, ** P < 0.01 vs. healthy control, # P < 0.05 vs. respective 
healthy exercised group, ## P < 0.01 vs. respective healthy exercised group.
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The expression levels of the angiogenic growth factors VEGF-A and VEGF-B and their receptors VEGFR-1 and VEGFR-2 cor-relat d po itively across study population (A-E)Figure 2
The expression levels of the angiogenic growth factors VEGF-A and VEGF-B and their receptors VEGFR-1 and VEGFR-2 cor-
related positively across the study population (A-E). TSP-1 and Cyr61 correlated positively with blood glucose concentration 
and also with each other (F-H). In Cyr61 and TSP-1 the variation between diabetic mice was markedly larger than between 
healthy mice, as can be seen in images g and h.
Cardiovascular Diabetology 2008, 7:13 http://www.cardiab.com/content/7/1/13could be affected by diabetes. The discrepancies between
these findings may arise from different models of diabetes
used (type 1, type 2 or hyperglycemia), and from the use
of different species (human, mouse, rat, rabbit). The
severity and duration of diabetes may also have influ-
enced the results. However, despite of the differences
between the findings from these studies, it seems that the
VEGF signaling pathway is somehow affected in skeletal
muscle by diabetes and/or hyperglycemia.
The observed increases in the expression levels of VEGF-A
and VEGFR-2 after the exercise bout in the present study
were modest compared to several previous studies, where
the highest expression (from 2 to 5-fold increase) has
been observed within the first hour after the exercise
[16,17,27,34-36]. We chose to study time points at 3 h
and 6 h post exercise to focus on the recovery period from
exercise. At these time points VEGF-A and VEGFR-2
expressions have been shown to remain elevated (see refs
above), but for the other proteins studied in the present
experiment the data from the recovery period is very lim-
ited. We also wanted to study the mRNA expression
changes in capillaries when blood flow has returned to
basal levels after the exercise bout and angiogenesis proc-
esses may proceed. Both animal and human studies have
shown that VEGF-A mRNA expression remains elevated
Capillaries and muscle fibers collected from the gastrocnemius muscle with laser capture microdissection were analyzed for the mRNA expres ion of VEGF-A an TSP-1Figure 3
Capillaries and muscle fibers collected from the gastrocnemius muscle with laser capture microdissection were analyzed for 
the mRNA expression of VEGF-A and TSP-1. Effects of exercise and diabetes in capillaries are shown in images A and B and in 
muscle fibers in C and D. The results are expressed as a fold-change (mean ± SE) from the healthy control group, which is set 
to 1. * P < 0.05 vs. healthy control, # P < 0.05 vs. respective healthy exercised group, † P < 0.05 vs. diabetic sedentary.Page 7 of 10
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8–24 h [16,26,27,37,38]. Different intensity, mode and
duration of exercise may also induce variation between
the findings of different studies.
The exercise intensity in the present study was chosen so
that the diabetic mice were also able to complete the one-
hour running bout. Thus, the relative intensity was prob-
ably higher for the diabetic mice than for the healthy
mice, as their exercise capacity was decreased due to dia-
betes. However, the changes in the angiogenic gene
expression were greater in the healthy mice than in dia-
betic mice. This further supports the suggestion that ang-
iogenic responses in skeletal muscle are reduced in
diabetic mice compared to healthy mice.
The strong correlations found between the proangiogenic
factors revealed that mice showing high expression of ang-
iogenic growth factors VEGF-A and VEGF-B, also showed
high expression of their receptors, especially VEGFR-2.
This suggests that the expression of angiogenic growth fac-
tors and their receptors are co-ordinately regulated in
response to exercise or elevated blood glucose, and that
their expression is controlled by a common upstream reg-
ulator. This idea needs to be further studied in the future.
The expression of thrombospondin-1, a known inhibitor
of angiogenesis [39], was increased both in the skeletal
muscle homogenates and in the capillaries of diabetic
mice. Our results concur with the findings by Stenina et
al., who found increased TSP-1 expression in the vessel
wall of diabetic Zucker rats [40], which is a model for met-
abolic syndrome. Recently, hexosamine pathway of glu-
cose catabolism was identified to mediate the
upregulation of TSP-1 activated by high glucose in human
aortic smooth muscle cells [41]. It has been proposed that
increased TSP-1 in blood vessels could be a direct
response of vascular cells to increased glucose levels and,
thus, a link between diabetes and atherosclerotic compli-
cations [40,41]. This idea is supported by the present find-
ings, as capillaries from diabetic mice expressed more
TSP-1 than capillaries from healthy mice. In addition to
atherosclerosis in larger blood vessels, TSP-1 may play a
role in capillary rarefaction in skeletal muscles, as has
been observed in obese Zucker rats [42] and in type 1 dia-
betic mice [4]. Interestingly, Olfert et al. recently showed
that a single exercise bout increased TSP-1 mRNA in
healthy rat skeletal muscle, but that after 3 consecutive
days of exercise this response was ablated [43]. In their
study the peak expression was detected 1 h after the cessa-
tion of exercise, and the increase was no longer statisti-
cally significant 2 h post exercise. This concurs with our
findings, since we did not observe any changes in TSP-1
expression in healthy mice either 3 h or 6 h after the exer-
cise bout in muscle homogenates. The healthy exercised
mice showed even decreased capillary expression of TSP-1
6 h post exercise compared to the sedentary controls (Fig.
3). In addition to increased angiogenic growth factors, the
decrease in TSP-1 in endothelial cells may further facilitate
angiogenesis processes post exercise. If the decrease in
TSP-1 expression occurs only in endothelial cells and not
in muscle fibers, it is very difficult to observe from muscle
homogenate samples.
The expression of Cyr61 was also increased in diabetic
muscles. Cyr61 (also known as CCN1) is an important
regulator of angiogenesis, endothelial cell function and
ECM modulation [44,45]. It also regulates the activity and
production of other angiogenic proteins like VEGF-A
[45,46]. Recently, in diabetic retina advanced glycation
end products were shown to induce the expression of
Cyr61 and connective tissue growth factor (CTGF/CCN2),
both of which belong to the same CCN protein family
[47]. In the diabetic retina the expression of Cyr61 and
CTGF seem to be related to the thickening of capillary
basement membrane [47]. If this is also the case in skele-
tal muscle, it may lead to excess accumulation of extracel-
lular matrix components and endothelial cell death,
leading to dysfunctional capillaries and capillary rarefac-
tion. There was a strong positive correlation between
blood glucose concentration and the expression of TSP-1
and Cyr61 in the muscle homogenates, indicating that the
expression of these genes is related to the level of hyperg-
lycemia. In the present study, exercise did not attenuate
the increased expression of either TSP-1 or Cyr61 in dia-
betic muscle.
On the basis of the present LCM results it seems that the
mRNA expression of VEGF-A and TSP-1 is more affected
by diabetes and exercise in capillaries than in skeletal
muscle fibers. The expression of VEGF-A in capillaries was
increased in the healthy exercised mice compared to con-
trols, and thus agreed well with the observations from the
muscle homogenates. However, the magnitude of the
increase was higher in capillaries. In the muscle fibers
extracted with LCM the expression of VEGF-A was
increased about 2-fold, but due to the small number of
mice in the analysis, it did not reach statistical signifi-
cance. This increase is similar to what Birot et al. observed
in rat single muscle fibers after a bout of endurance exer-
cise (~90%) [48]. Capillary TSP-1 expression was reduced
in the healthy exercised group and increased in both dia-
betic groups compared to healthy controls. These
increases in capillary TSP-1 due to diabetes also resemble
the changes detected in the muscle homogenates. Taken
together, these findings show that diabetes- and exercise-
induced effects on angiogenic factors are stronger in cap-
illary endothelial cells than in muscle fibers. This is inter-
esting, since recently Lee and co-workers showed that
autocrine VEGF-A signaling in endothelial cells is requiredPage 8 of 10
(page number not for citation purposes)
Cardiovascular Diabetology 2008, 7:13 http://www.cardiab.com/content/7/1/13for vascular homeostasis, and could not be compensated
with paracrine VEGF-A (e.g. from skeletal muscle fibers)
[49]. Capillaries in the mouse skeletal muscle are small,
and it is possible that cells other than endothelial cells
located close to capillaries were also collected in the LCM
procedure. However, the majority of the cells in the assay
were endothelial cells, and the differences observed in
mRNA expression between muscle fibers and capillaries
indicate that representative cell populations were col-
lected. This was controlled by setting the laser pulse diam-
eter always smaller than 10 μm and examining the
collecting cap microscopically after removing it off the
sample.
The reduced capability of diabetic compared to healthy
endothelial cells to increase VEGF-A production in
response to exercise stimulus may be related to the
impaired vascular function and capillary rarefaction in
diabetic skeletal muscle. In skeletal muscle and myocar-
dial ischemia studies, diabetic animals exhibit impaired
angiogenesis, and this impairment has been linked to sev-
eral proteins in angiogenesis signaling [5,8-11]. Gene
transfer with VEGF-A was able to promote angiogenesis in
the myocardium of type 2 diabetic mice [10], but so far
angiogenic gene transfer studies in humans have not been
very successful [50]. Exercise may positively affect ang-
iogenic signaling by stimulating the whole signaling path-
way and thus, be effective in the prevention and treatment
of peripheral vascular problems in diseases such as diabe-
tes.
Conclusion
The present findings showed that angiogenic growth fac-
tor response to exercise is attenuated in diabetic compared
to healthy mice in skeletal muscle. The present results
confirmed our earlier observation that antiangiogenic
TSP-1 expression is significantly increased in diabetic
muscles. This occurs especially in capillaries, which could
be a direct cause to capillary rarefaction seen in diabetic
muscles. This study also showed provided evidence that
both diabetes and exercise affect the production of ang-
iogenic factors in capillaries and in muscle fibers, the
responses being more pronounced in capillaries.
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